Published June 8, 2026
Imagine going to the doctor’s office with your spouse to learn that your unborn child carries genetic traits likely to cause blindness. The doctor tells you about available gene therapies that can “edit” out the genes causing blindness. Would you take advantage of this technology to spare your child from what is now an unnecessary hardship?
This is no longer just a hypothetical (even if the technology is not yet commercially available). Last week, the New York Times published a blockbuster bioethics story that should prompt all would-be parents to consider what the future of gene editing holds for childbearing.
Click here to continue reading.
Andrew T. Walker, Ph.D., is a Fellow in the Evangelicals and Civic Life Program at The Ethics and Public Policy Center. He is also the Dean of the School of Theology and Professor of Christian Ethics and Public Theology at The Southern Baptist Theological Seminary in Louisville, Kentucky, and the founding Managing Editor of WORLD Opinions. He co-hosts The Bully Pulpit, a weekly podcast exploring faith, culture, and politics from a conservative Christian perspective.
